RE: Is covid tests still in play.7 Apr 2022 11:12
Myluck
Don’t expect reasoned debate on here if you question the god that is Avacta.
IMO you can kiss goodbye to any significant revenue from Covid LFT. it is too expensive, the market is saturated and it looks as if it takes too long to tweak for new variants.
However the long term potential for LFTs for all sorts of other things looks very bright for Avacta but I doubt we’ll get a dividend from them until 2024.
Just my opinion. Meanwhile let’s look forward to a great uplift in SP this year from AVA6000 and more importantly the lives your investment is gonna help to save.
GLA